Kellie A. McElhaney is a leading expert on equity fluent leadership, value-creating strategies of diversity and inclusion, and corporate social responsibility. She is on the Berkeley Haas faculty as a Distinguished Teaching Fellow and is the Founding Director of the Center for Equity, Gender and Leadership (EGAL).
Launched in November 2017, EGAL’s mission is to educate equity fluent leaders to ignite and accelerate change. Equity fluent leaders understand the value of different lived experiences and courageously use their power to address barriers, increase access, and drive change for positive impact. McElhaney helped develop the equity fluent leadership concept and teaches it across the country and around the world.
In 2003, McElhaney founded the Center for Responsible Business, solidifying corporate responsibility as a core competency and competitive advantage for the Haas School. Haas was rated #1 in the world for corporate responsibility by The Financial Times. She received the Founder and Visionary Award at Haas in 2013 for this work.
McElhaney wrote a book entitled “Just Good Business: The Strategic Guide to Aligning Corporate Responsibility and Brand.” She writes case studies of companies who are investing in women and equity-fluent leadership (Wal-Mart, Gap, Inc., Boston Consulting Group, Zendesk), and conducts research in the area of equal, pay, conscious inclusion, equity fluent leadership, and value-creating strategies of diversity and inclusion.
McElhaney consults and keynotes for Global 1000 companies and organizations all over the world on her areas of expertise, and has a TED talk.
“While the commitment to diversity and an inclusive work environment is there, too few have a handle on solutions".
When you hear that someone makes a list of top most influential leaders, it’s easy to assume they were driven by a clear vision for their career since they were young.,,There’s a strong business case to be made for promoting women’s involvement in the business world, let’s not forget; Harvard-Haas Business School’s Kellie McElhaney has made that case for years, using hard numbers to demonstrate that companies with a larg
Jason McLellan specializes in understanding the structure and function of viral proteins, including those of coronaviruses. His research focuses on applying structural information to the rational design of vaccines and other therapies for viruses, including SARS-CoV-2, the novel coronavirus that causes COVID-19. McLellan and his team collaborated with researchers at the National Institute of Allergy and Infectious Diseases’ Vaccine Research Center to design a stabilized version of the SARS-CoV-2 spike protein, which forms the basis of several leading COVID-19 vaccine candidates, including those by Moderna, Novavax, Johnson & Johnson and Pfizer/BioNTech.
Dr. McLellan earned a BS in chemistry with an emphasis in biochemistry from Wayne State University in Detroit, Michigan. Afterward, he obtained his PhD from the Johns Hopkins University School of Medicine in Baltimore, Maryland in the laboratory of Dr. Daniel Leahy. He then carried out postdoctoral research at the National Institutes of Health's Vaccine Research Center in the laboratory of Dr. Peter Kwong and in collaboration with Dr. Barney Graham. In the Fall of 2013, he joined the faculty at the Geisel School of Medicine at Dartmouth in the Department of Biochemistry, and in January 2018 he moved his laboratory to the University of Texas at Austin and became a member of the Department of Molecular Biosciences.
2020 William Prusoff Memorial Award (International Society for Antiviral Research)
2019 Viruses Young Investigator in Virology Prize
2018 American Crystallographic Association Etter Early Career Award
2015 Charles H. Hood Foundation Child Health Research Award
2012 Norman P. Salzman Memorial Award in Virology
"We knew exactly what mutations to put into this, because we’ve already shown these mutations work for a bunch of other coronaviruses.”
McMichael has published numerous articles and book chapters on the subjects of scalp and hair disorders and quality of life issues surrounding disorders of pigmentation. She is listed in Best Doctors in America and is a diplomat of the American Board of Dermatology. McMichael has served on several editorial review boards and is a contributing editor for Cosmetic Dermatology as well as a contributing editor for reviews in The Dermatologist.
Laxmi Mehta, M.D., FACC, FAHA is the Director of the Women’s Cardiovascular Health Program and an Associate Professor of Medicine at The Ohio State University Wexner Medical Center. Dr. Mehta is also the Associate Program Director for Education for Ohio State’s Center for Women’s Health.
She is the President of the Ohio Chapter of the American College of Cardiology and has previously served two terms as Secretary/Treasurer for the Ohio-ACC Chapter. Additionally, she is the Immediate Past President of the metro Columbus Board of Directors for the American Heart Association and now currently serves on the Great Rivers Affiliate Board for the American Heart Association. She sits on several national committees for both the American College of Cardiology and the American Heart Association. Dr. Mehta was chosen by Business First Magazine as one of Columbus' Top 40 under 40 in 2010 and honored as one of 12 women for the 2012 Women for Economic Leadership (WELD) Women You Should Know Calendar Honoree.
She specializes in women’s cardiovascular health, prevention and cardiac imaging. Dr. Mehta is an avid promoter and educator on women’s cardiovascular health and has published a number of peer-reviewed articles and book chapters. She is a Fellow of the American College of Cardiology and the American Heart Association. She received her M.D. degree from Northeastern Ohio Universities Colleges of Medicine and Pharmacy in Rootstown, Ohio in 1998. She completed her Internal Medicine residency training and Clinical Cardiology fellowship training at William Beaumont Hospital in Royal Oak, Michigan in 2001 and 2005.
“Unfortunately, many women don’t make their own personal health their priority,” she says, “which contributes to more favorable outcomes in men versus women after a heart attack. From my experience, most men attend cardiac rehab, unless work issues preven,“Over the last 10 years or so, we’ve learned that women’s hearts are different than men’s in some significant ways, and while that’s helped reduce mortality, there’s much more to know,” said Mehta, who is also director of Ohio State’s Women's Cardiovascul
Dr. Mielcarek believes that individualizing treatment according to the patient's needs and philosophy, combined with incorporating up-to-date research knowledge, are key ingredients for excellent patient care.
Blood stem cell and bone marrow transplantation for hematologic malignancies
Graft-versus-Host Disease (GVHD)
Medical Director, Adult Blood and Marrow Transplant Program, Seattle Cancer Care Alliance
Member, Clinical Research Division, Fred Hutch
Professor of Medicine, Department of Medical Oncology, University of Washington
Education and Training
MD: Freie Universität Berlin, 1986
PhD: Freie Universität Berlin, 1987
Residency: Freie Universität Berlin, Internal Medicine, 1987-1993
Research Fellowship: Fred Hutchinson Cancer Research Center, 1994-1999
Residency: University of Washington, Internal Medicine, 1999-2000
Fellowship: University of Washington, Medical Oncology, 2000-2003
Natalie B. Milman, Ph.D. is Professor of Educational Technology and Director of the Educational Technology Leadership Program at The George Washington University and a member of the interdisciplinary Human-Technology Collaborations Ph.D. program and research lab (go.gwu.edu/htc). She is on the steering committee and a member of GW’s Academy of Distinguished Teachers and winner of the 2017 Bender Teaching Award. Her research focuses on the design of instruction and models for the effective leadership and integration of technology at all academic levels; online student support needs, engagement, and learning; issues of diversity, inclusion, and digital equity; and the use of digital portfolios for professional development.
She serves as the co-editor of the Current Practice Section of "Contemporary Issues in Technology and Teacher Education" and has published numerous journal articles, including in "Computers in the Schools," "Journal of Research on Technology and Education," "Journal of Technology and Teacher Education," "Online Learning," and the "Quarterly Review of Distance Education." She presents frequently at conferences and has co-authored several book chapters and books. Her most recent book is entitled, "Teaching Models: Designing Instruction for 21st Century Learners."
Dr. Milman earned a doctorate in Instructional Technology from the University of Virginia’s Curry School of Education with a graduate specialization designed to prepare technology leaders. She began her career in education as a second grade, science specialist, mentor, and technology teacher in Los Angeles County, California. She has taught at the graduate school level since 1997 and online since 2001.
“I believe students need to make a distinction between their perceptions and experiences of the residential college experience and a well-designed online class and you know, it’s hard to take those two apart because what many students have experienced is a residential college experience, but that’s not everyone’s experience.”,“This is hard. It’s hard on all of us. And for some extremely difficult – some of us have experienced a great deal of loss. If there's anything that I have seen really come to the fore – it’s that idea of caring and the need for social and emotional wellbeing.”
I have taught online for nearly 20 years. As an online professor at George Washington University, my courses continued through the 9/11 terrorist attacks, beltway snipers, Hurricane Isabel, the H1N1 virus, and "Snowmaggedon.,An article written by Natalie B. Milman in Education Week, a news journal focusing on K-12 education, on March 30, the day the city’s first coronavirus death hit the news, described what was going on in the nation’s schools as “emergency remote teaching.”
As President and CEO, Elizabeth Mitchell advances the organization’s strategic focus areas of redesigning health care delivery, driving affordability, and optimizing markets. Mitchell leads PBGH in mobilizing purchasers, to support high-quality affordable care – achieving measurable impacts on health outcomes and affordability including quality, patient-reported outcomes and satisfaction, and the appropriateness of delivered care.
At PBGH, Mitchell leverages her extensive experience in working with healthcare purchasers, providers, policymakers, and payers to improve quality and cost. Mitchell previously served as Senior Vice President for Healthcare and Community Health Transformation at Blue Shield of California, during which time she designed Blue Shield’s strategy for transforming practice, payment and community health. Mitchell also served as the President and CEO of the Network for Regional Healthcare Improvement (NRHI), a network of regional quality improvement and measurement organizations; served as CEO of Maine’s business coalition on health (the Maine Health Management Coalition); worked within an integrated delivery system (MaineHealth); and was elected to the Maine State Legislature, serving as a State Representative.
Mitchell served as Vice Chairperson of the U.S. Department of Health & Human Services Physician-Focused Payment Model Technical Advisory Committee, Board and Executive Committee Member of the National Quality Forum (NQF), Member of the National Academy of Medicine’s “Vital Signs” Study Committee on core metrics, and a Guiding Committee Member for the Health Care Payment Learning & Action Network.
Mitchell holds a degree in religion from Reed College and studied social policy at the London School of Economics.
Anti-competitive practices are increasingly concerning to large employers. What we’re seeing happening right now is the collapse of independent primary care,"[...] it is a big ask to ask a customer to change an industry; I can’t think of any other industry that expects that other than health care."
Patricia E. Molina, MD, PhD, is the Richard Ashman Professor and Head of Physiology, and Director of the Alcohol and Drug Abuse Center at LSU Health Sciences Center New Orleans’ School of Medicine. Dr. Molina's training as a physician prior to completing training in physiology provides her with a unique systems approach to study the biomedical consequences of chronic heavy alcohol use, with emphasis on the pathophysiological mechanisms that aggravate HIV disease progression. Her research focuses on the interaction of chronic alcohol consumption on progression of HIV disease in preclinical models and in translational studies. Her research involves integrating in vivo with ex vivo approaches to understand the contribution of organ systems to disease pathogenesis. Another area of research interest and ongoing investigations is the interaction of alcohol with outcomes from traumatic brain injury. Her work examines the mechanisms that lead to greater alcohol drinking during the post-injury phase, and the potential role of the endocannabinoid system in modulating those responses. Dr. Molina is interested in translating research findings to the community at large, and in educating the lay public on the consequences of excessive alcohol consumption. This is particularly relevant to young students and parents as they make decisions on alcohol drinking throughout their life.
It is not just about knowing that driving under the influence is dangerous. It is about understanding how alcohol affects all organs in the body and what the signs that should be recognized by peers that you someone is in danger.
Senior advisor for global health to Georgetown University President John J DeGioia; senior fellow, McCourt School of Public Policy; and senior scholar, O’Neill Institute for National and Global Health Law. Monahan served as the special advisor for Global Health Partnerships at the US Department of State (2010-2014) as well as a counselor to the secretary and director of global health affairs at the U.S. Department of Health and Human Services (2009-2010). While at HHS, Monahan served as the U.S. Government’s primary contact with the leadership of the World Health Organization during the 2009 H1N1 pandemic and helped coordinate the U.S.-led diplomatic strategy to secure commitments from developed countries for donating influenza vaccines to low-income countries.
Monahan can discuss the obligation of WHO and member states to support and respond to disease outbreaks.
Gilberto Montibeller is a Full Professor of Management Science at Loughborough University (UK) and a Senior Research Fellow at the University of Southern California (USA). He joined Loughborough in 2015 after spending a decade as a tenured faculty in the Department of Management at the London School of Economics. He has taken senior management roles at Loughborough University, as Associate Dean for Enterprise and Head of the Management Science and Operations Group.
He has a BSc in Electrical Engineering (UFSC), MSc in Engineering Economic Analysis (UFSC) and PhD in Engineering Economic Analysis (UFSC/Univ. of Strathclyde). After his doctorate, he continued his studies as a pos-doc research fellow in Management Science at the University of Strathclyde.
Prof Montibeller is an expert on strategic risk and decision analysis. His main areas of application are global health prioritisations and health risk management, having led projects for the World Health Organization, Pan-American Health Organization, UK Department for Environment, Health and Rural Affairs (DEFRA), UK Department of Health, the Food and Agriculture Organization of the United Nations (FAO), USAID, among others.
He is Associate Editor of the Informs Decision Analysis journal and has served as area editor of the Journal of Multi-Criteria Decision Analysis. He has published widely in top journals in decision sciences. The quality of his research has been recognised by best publications awards from the Institute for Operations Research and the Management Sciences (Informs), the Society for Risk Analysis, and the International Society on Multi-Criteria Decision Making.
He has been a visiting scholar at the Massachusetts Institute of Technology (MIT), the International Institute for Applied Systems Analysis (IIASA, Austria), and CNRS Lamsade at Paris Dauphine University (France). He is a visiting professor at the University of Sao Paulo (Brazil) and Adjunct Professor at the Hertie School of Government (Germany) and IE Business School (Spain).
Prof Montibeller has extensive experience with executive education over more than 20 years, having taught courses at the LSE executive schools (UK), LSE corporate education (UK), Warwick Business School (UK), Hertie School of Government (Germany) and IE Business School (Spain).
“There are a lot of parallels between health threats and security threats, like terrorism. And one thing we know about these kinds of threats is that the perceived risk is very high. Both because it is dreadful, the fear of dreadful consequences, but also because of the unknown caused by an emerging disease and so not only you have actual risks but also perceived risks that play a role and while you can manage actual risks, we have to just try to also manage those passive risks”,“The health capabilities of the current system, the American system, the Western European system is mainly focused on chronic diseases and I think we could learn from the mediator on how to be prepared against infectious diseases. Pandemics, endemics, and everything that capacity planning can provide us. So that’s the second issue.”
Lurking within every Premier League statement about ‘Project Restart’ is a supposedly comforting reference to their “priority” of health and safety.,“Epidemiologists have been driving policy, which is great, but we need to know other impacts beyond the number of people infected and the care they need. There is a lot of science, such as risk analysis, that hasn’t been included in this debate."
,“Covid-19 is a classic example of a high perceived risk. Any policy has to deal with both perceived and actual risk and understand why people are feeling afraid.
“You cannot open the economy and expect activity to resume at steady levels, because there
Dr. Larissa Mooney is a board certified addiction psychiatrist with expertise in the treatment of substance use disorders and psychiatric comorbidity. After obtaining residency training at New York University, she completed a fellowship in addiction psychiatry at Cedars-Sinai Medical Center. Dr. Mooney is an Associate Clinical Professor of Psychiatry at UCLA and Director of the UCLA Addiction Medicine Clinic, where she teaches psychiatrists in training in the clinical management of dual diagnoses. Dr. Mooney serves on the Executive Board of Directors for the American Academy of Addiction Psychiatry (AAAP). She has conducted research on treatment interventions for addictive disorders, including methamphetamine, cocaine and opioid use disorder and has received funding from the National Institute on Drug Abuse (NIDA) to study clinical outcomes in individuals with cannabis use disorder.
"Smoking is inherently unhealthy, and by sending the message that we're smoking something to take the edge off or to cope with pain, that sends a message to our children.”
"One's reaction time may be slowed; coordination, the ability to respond in an emergency may be impaired.",,There is a window of opportunity of usually several hours between when someone who has overdosed might just be looking sleepy and when he or she may die. In some of these situations, the person may never make it to the emergency room.
Dr. Amy Moore is the Director of Science and Research at GO2 Foundation. Dr. Amy C. Moore is a PhD-trained virologist and cancer researcher and has spent over a decade working on large statewide and multi-institution initiatives in cancer and vaccines. She currently serves as Director of Science & Research for the GO2 Foundation for Lung Cancer and also works closely with GO2 Foundation's sister organization, the Addario Lung Cancer Medical Institute (ALCMI), to build research capacity in emerging areas of concern to the lung cancer community.
Because of her virology training and position as a leader in the advocacy community, Dr. Moore has become a highly sought-after expert to discuss the intersection of lung cancer and COVID-19. Since early March, she has participated in over half a dozen panel discussions, webinars, and interviews with leading groups such as IASLC, CURE, US News & World Report to discuss the threat COVID-19 presents to patients with lung cancer and how we can mobilize research to understand this risk.
“We are looking to source the best science to help the greatest number of people.”,"I alluded to some of the concerns that emerged as a result of the survey and I think first and foremost, the early reports that were coming out, really spoke to the increased risk to the lung cancer community." ,“It's clear that lung cancer patients are anxious. They are fearful because what our data has shown is that lung cancer patients are uniquely vulnerable to this disease and they have higher rates of severe disease and increased mortality.”
,“There have been a number of studies that have emerged since the start of the pandemic, looking at the increased risk of patients with various comorbidities - not limited to cancer. We've heard talk about diabetes or hypertension. So, what we do know is that cancer puts patients at added risk for the worse outcome and lung cancer in particular, of the various malignancies seems to be.”
,“I'm encouraged by the fact that we have multiple shots on goal, and I think that
Don Moore is the Lorraine Tyson Mitchell Chair in Leadership and Communication at Berkeley Haas. He received his PhD in Organization Behavior from Northwestern University. His research interests include overconfidence—including when people think they are better than they actually are, when people think they are better than others, and when they are too sure they know the truth. He is only occasionally overconfident.
Expertise and Research Interests:
2016 – present, Professor, Management of Organizations Group, Haas School of Business
2010 – 2016, Associate Professor, Management of Organizations Group, Haas School of Business
Courtesy appointment in the Department of Psychology, University of California, Berkeley
2015 – present, Faculty Director, Xlab
2000 – 2010, Assistant to Associate Professor of Organizational Behavior, Tepper School of Business, Carnegie Mellon University
“So many people actively pursue a strategy of trying to fool themselves into being more confident. Confidence that doesn’t match reality or ability is just delusion.” ,Understanding the limits of confidence is key to overcoming this pandemic — and the next. Research on confidence has documented the dangers of being too confident. Overconfident people fail to plan for threats, such as COVID-19. Overconfident leaders make mistakes that put others at risk.
Ann Morning, author of The Nature of Race: How Scientists Think and Teach about Human Difference (University of California), is an associate professor of sociology at New York University. She is a member of the U.S. Census Bureau National Advisory Committee on Racial, Ethnic, and Other Populations and has served as a statistician for the bureau. Morning has also authored reports for the National Research Council’s Committee on the Use of Social Science Knowledge in Public Policy and the United Nations’ Statistics Division. Morning is also the academic director of 19 Washington Square North, NYU Abu Dhabi’s home in New York.
Morning previously worked as an economist at the Federal Reserve Bank of New York and as a diplomat in the U.S. Foreign Service. From 1995 to 1997, she was an Assistant Dean for Academic Affairs at Columbia University’s School of International and Public Affairs.
Morning received her B.A. magna cum laude from Yale, her Master’s in International Affairs from Columbia, and her Ph.D. in sociology from Princeton. She also studied at the Institut d’Etudes Politiques in Paris.
Stephen Mosher is a professor of sport management and media. Mosher has coached youth sports himself for over 25 years and studies the issues of sport in popular culture. He is currently working on an ethnography of bowling, which discusses how that sport plays a central role in the civic engagement of blue collars workers. In 2001, he wrote a series of columns for ESPN.com on the Little League World Series scandal involving pitcher Danny Almonte, who played despite being two years over the age limit.
“The balance of power in professional sports now rests more with the performers than the owners. Without a labor force, Robert Kraft has nothing but an empty stadium. He has to let his employees make these political statements if he wants to win.”
Amr M. Moursi, DDS, PhD, is a professor and chair of the Department of Pediatric Dentistry at NYU College of Dentistry. His research focuses on early childhood oral health, including the use of silver diamine fluoride (SDF) to fight cavities, birth defects of the head and skull, nutrition and oral health, and developing the pediatric dentistry workforce.
Dr. Moursi is the author or co-author of more than 100 published articles, book chapters, and policy briefs, and is the editor of the textbook "Clinical Cases in Pediatric Dentistry" (Wiley-Blackwell). He is also a contributor for the 2020 U.S. Surgeon General’s Report on Oral Health.
Dr. Moursi is a board-certified diplomate of the American Board of Pediatric Dentistry. He serves on the Executive Committee and as a National Spokesperson for the American Academy of Pediatric Dentistry (AAPD). He has extensive experience with print and broadcast media and is host of "The Dental Health Show" on Doctor Radio, SiriusXM satellite radio.
Watch Dr. Moursi on ABC 7 discussing how to keep baby teeth healthy: https://youtu.be/ybKe5G1kodw
Dr. Moye has over 25 years of experience in the field of human resources with particular expertise in helping individuals develop leader skills. She has spent the last 10 years focused on the practice of leadership development across academic, industry, and government settings. She has experience both designing and delivering leadership development solutions across the full range of development activities including formal classroom curricula, experiential development activities, executive coaching, and leader assessments and debriefs.
Dr. Moye’s background has given her broad exposure to the practice of leadership development. As a former faculty member of Vanderbilt University, Neta was the founding faculty director for Vanderbilt University’s Owen Graduate School of Management Leadership Development program; a program ranked among the top 10 in the world by BusinessWeek rankings. She also supported Executive Education at Vanderbilt, helping to build and deliver innovative leadership development programming for corporate clients. As a consultant with PDRI, A CEB Company, she led the design and development of cutting edge products and services to help clients build their next generation of leaders in both government agencies and private sector corporations.
The particular leadership development challenge that Dr. Moye is focused on at the moment is how to help leaders leverage the developmental power of day-to-day experiences, and how to more fully integrate experiential learning into formal leadership development programs. This includes exploring how to increase a leader’s learning agility; that is, their willingness and ability to learn from experience.
Dr. Moye’s involvement in leadership development also includes being an award winning instructor; she has designed and delivered courses to thousands of individuals spanning private and public sector, all levels of leaders, and both non-degree and degree students within three top-25 MBA programs. Most recently, in her work with the Department of Defense, the World Bank, and the World Health Organization, Dr. Moye has designed and delivered workshops to global audiences of staff and managers on the topics of adaptability, conversations about performance, and collaborating to improve performance.
“None of the stories that we learned about in the #MeToo movement was a small, one-time, accidental incident in which some man says to some woman at work, ‘I like your dress,’’’ Moye said. “These stories are of men who are knowingly, willingly abusing power, usually repeatedly, in order to get sexual favors from women.”
Ricardo F. Muñoz, Ph.D. is a depression prevention and treatment researcher and Distinguished Professor of Clinical Psychology at Palo Alto University. From 1977 to 2012, he was professor of psychology at the School of Medicine of the University of California, San Francisco (UCSF), based at San Francisco General Hospital (SFGH), where he served as Chief Psychologist for 26 years. Dr. Muñoz has been the recipient of many awards, including the Martin Luther King, Jr. Award from UCSF and the George Sarlo Award for Excellence in Teaching from the UCSF Department of Psychiatry. He is now Professor Emeritus at UCSF. He has been a pioneer in the development of Internet interventions for health since the 1990’s and was a founding member of the board of directors for the International Society for Research on Internet Interventions from 2010 to 2013. He has most recently founded i4Health, an institute dedicated to developing, evaluating, and disseminating evidence-based psychological interventions in multiple languages for people worldwide using Internet sites and mobile applications.
Muñoz immigrated from Perú to the Mission District in San Francisco in 1961, at age 10. He did his undergraduate work at Stanford and his doctorate at the University of Oregon in Eugene. He was the first psychologist to join the faculty of the UCSF Department of Psychiatry at San Francisco General Hospital in 1977. In 1985, he founded the SFGH Depression Clinic, the first cognitive-behavioral service at UCSF. He became Chief Psychologist at SFGH in 1986, and Director of the Clinical Psychology Training Program from 1992 to 2012. His research focuses on the development of prevention and treatment interventions for depression and applications of these methods to help people stop smoking. He founded the UCSF/SFGH Latino Mental Health Research Program in 1992. He began work on international randomized trials via the Internet in 1998, and founded the UCSF/SFGH Internet World Health Research Center in 2004. He was the PI on the first randomized controlled trial to prevent major depression. He has served on both Institute of Medicine committees which produced major reports on prevention of mental disorders in 1994 and 2009. His latest contributions to the area of prevention of depression include articles in the Annual Review of Clinical Psychology (2010), the American Psychologist (2012), and a chapter in the Handbook of Depression (2014).
Ultimately, massive open online interventions will need to be created (similar to the massive open online courses that are delivered on the Internet for free). These would allow anyone to obtain information and tools to help them stave off depression, at times and places that are convenient to them.
Dr. James M. Musser his medical training at the University of Rochester and his residency in laboratory medicine at the University of Pennsylvania. He also completed postdoctoral research in molecular evolutionary genetics at Pennsylvania State University. Musser conducts research that focuses on the molecular basis of host-pathogen interactions in group A Streptococcus and Mycobacterium tuberculosis. His areas of expertise include Mycobacterium tuberculosis, Group A Streptococcus, infectious disease and antibiotic-resistant bacteria.
Professor of Pathology Mayo College of Medicine, Consulting Pathologist, Department of Pathology, Mayo Clinic, Jacksonville, Florida, Chair of College of American Pathologists Council on Scientific Affairs.
Dr. Raouf E. Nakhleh has been practicing medicine for 29 years. Dr.Nakhleh graduated from the Wayne State University School of Medicine in 1985. He practices medicine in Jacksonville, FL, and specializes in Anatomic Pathology & Clinical Pathology. Dr. Nakhleh is affiliated with Mayo Clinic.
His interest includes Transplantation, Liver disease, Quality Improvement, Laboratory Medicine, Pathology.
“If you were infected and you’ve gotten over the illness, we want to see if you have immunity so the illness won’t affect you again. That's one reason. Another reason we do this testing is to potentially use the individual’s plasma to treat other patients with active infections. The other, the last point I want to make about having antibodies is that this is one of the mechanisms that’s used to check the response to a potential vaccine.”,“Part of the problem is even if you have good tests if the prevalence of the infection is low, your accuracy really drops. If the prevalence is very high then the accuracy gets better and that’s why it can be false, you get the wrong results in up to 50% of the cases.”
“In the midst of the enormous pressure laboratories are facing, along with everyone working in health care during the COVID-19 crisis, laboratories are seeking to measure their performance when testing for the disease,”